home / stock / cdtx / cdtx news

CDTX News and Press, Cidara Therapeutics Inc. From 09/14/20

Stock Information
Company Name: Cidara Therapeutics Inc.
Stock Symbol: CDTX
Market: NASDAQ
Website: cidara.com
Menu
CDTX CDTX Quote CDTX Short CDTX News CDTX Articles CDTX Message Board
Get CDTX Alerts

News, Short Squeeze, Breakout and More Instantly...
CDTX - Cidara Therapeutics to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020

SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present two ora...
CDTX - CODX, VJET, NKLA and CRBP among midday movers

Gainers:  A-Mark Precious Metals (NASDAQ: AMRK )   +23% . More news on: A-Mark Precious Metals, Inc., Natural Health Trends Corp., Biofrontera AG, Stocks on the move, , Read more ...

CDTX - Cidara Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President ...

CDTX - Cidara Therapeutics EPS misses by $0.14, misses on revenue

Cidara Therapeutics (NASDAQ: CDTX ) : Q2 GAAP EPS of -$0.45 misses by $0.14 . More news on: Cidara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CDTX - Cidara Provides Corporate Update and Reports Second Quarter 2020 Financial Results

SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today reported financial results for the three months ...

CDTX - Cidara Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

SAN DIEGO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President a...

CDTX - Cidara Therapeutics Announces Formation of Scientific Advisory Board

SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced the formation of a scientific advisory...
CDTX - Cidara Therapeutics to Participate in B. Riley Virtual Summer Series Panel on Antiviral Therapeutics

SAN DIEGO, July 17, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph.D., President a...

CDTX - ORGS, SLNO, CDTX, BLPH, ARCT added to Indexes

Orgenesis (NASDAQ: ORGS ) added to the Russell 3000 Index, effective after the market open June 29 . More news on: Orgenesis Inc., Soleno Therapeutics, Inc., Cidara Therapeutics, Inc., Healthcare stocks news, Read more ...

CDTX - Cidara Therapeutics Added to Russell 3000® Index

SAN DIEGO, June 29, 2020 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced that it has been added to the Russell ...
Previous 10 Next 10